|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
2.46%
|
US
|
NASDAQ
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
0.87%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
0.83%
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
0.81%
|
US
|
NASDAQ
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
0.80%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.80%
|
US
|
NASDAQ
|
|
HZNP
|
Horizon Pharma, Inc.
|
0.78%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
0.77%
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
0.75%
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
0.74%
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
0.74%
|
US
|
NASDAQ
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
0.73%
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
0.73%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
0.73%
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
0.72%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
0.72%
|
US
|
NASDAQ
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
0.71%
|
US
|
NASDAQ
|
|
EXAS
|
Exact Sciences Corporation
|
0.71%
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
0.71%
|
US
|
NASDAQ
|
|
ALT
|
Altimmune, Inc.
|
0.71%
|
US
|
NASDAQ
|